Numaferm and zoetis sign license agreement to collaborate on developing and producing proteins and peptides

DÜsseldorf, germany / accesswire / july 6, 2023 / numaferm, a germany-based biotech company, specialized in the production of pepteins, and zoetis, the global leading animal health company, have signed a licensing agreement for the development and production of defined veterinary therapeutics. financial details of the deal were not disclosed.
ZTS Ratings Summary
ZTS Quant Ranking